Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of Hysterectomy After Chemoradiation Therapy for Stage IB2/II Cervical Cancer

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* operable Stage IB2/II Cervical Cancer~* adenocarcinoma, squamous cell or adenosquamous carcinoma~* Patient between 18 and 70 years old~* No lombo-aortic lymph node invasion at baseline~* Previous 45 grays external pelvic radiation with concomitant chemotherapy (cisplatin 40 mg/m2/week corresponding to 5 cycles)~* Followed by a 15 grays utero-vaginal brachytherapy, eventually combined with a 6th cycle of chemotherapy (cisplatin 40 mg/m2)~* with a pelvic boost if lymph node or parametrial invasion~* No macroscopic residual tumor after 6 to 8 weeks after brachytherapy.~Exclusion Criteria:~* Other tumor histology (neuro-endocrine)~* Stage \> II (FIGO 1995) at baseline~* Patient with remaining cervical cancer (after sub-total hysterectomy)

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- with hysterectomy (Type: EXPERIMENTAL): None
- without hysterectomy (Type: NO_INTERVENTION): None

Based on this trial design, predict the completion outcome and termination type (if applicable).